Pharmaceutical | Tokio X'press - Part 57

DOH分配P18-M用于流感药物Avigan作为COVID-19治疗的试验

05/25/20 MondayBy Tokio X'press flu, Drugs, Pharmaceutical

RDIF和ChemRar启动Favipiravir临床试验的最终阶段-

05/23/20 SaturdayBy Tokio X'press flu, Drugs, Pharmaceutical

COVID-19：Nichiiko增产Futhan（nafamostat）：向Latus Therapeutics提供

05/22/20 FridayBy Tokio X'press flu, Pharmaceutical

COVID-19：卫材开始“ Eritlan”的临床试验：严重脓毒症/候选药物

05/21/20 ThursdayBy Tokio X'press flu, monitor, Pharmaceutical

COVID-19：创新型氧化剂MA-T®：对98％以上的病毒进行消毒

05/20/20 WednesdayBy Tokio X'press hospital, flu, Medical science, Material, Pharmaceutical

1 … 56 57 58 … 111